Do We Still Need Lead-in Dosing of Nevirapine in Hiv-Infected Patients Who Are Receiving Rifampicin-Containing Antituberculous Therapy?
Resource
CLINICAL INFECTIOUS DISEASES v.49 n.9 pp.1452-1453
Journal
CLINICAL INFECTIOUS DISEASES
Journal Volume
v.49
Journal Issue
n.9
Pages
1452-1453
Date Issued
2009
Date
2009
Author(s)
CHANG, SUI-YUAN
LIN, SHU-WEN
HUNG, CHIEN-CHING